Neuroprotection Bundles Comatose Survivors for in Cardiac Arrest Trial

NANot yet recruitingINTERVENTIONAL
Enrollment

1,008

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2027

Conditions
Cardiac ArrestPost-cardiac Arrest Care
Interventions
OTHER

Goal-directed care bundle for neuroprotection

"Reducing lactate (Lac) to \<2 mmol/L within 24 hours.Maintaining systolic arterial pressure at 120-140 mmHg.~Elevating the head-of-bed to 30 degrees. Maintaining body temperature ≤37.7°C. Maintaining PaO₂ at 70-100 mmHg. Maintaining PaCO₂ at 35-45 mmHg. Maintaining blood glucose at 7.8-10.0 mmol/L. Maintaining serum sodium level at 140-150 mmol/L. If any management parameter falls outside the target range, immediate correction is required within 24 hours of enrollment and must be sustained for 72 hours. Given the dynamic nature of some targets (e.g., mean arterial pressure, body temperature), a degree of flexibility is permitted in achieving these goals. Patients are considered to have successfully implemented the neuroprotection bundle if the achievement rate of individual targets is ≥80% and all targets are met. The medications(antipyretics, vasopressor agents) is acceptable to achieve these targets."

OTHER

Usual Care

Usual care decisions about the location of care delivery, investigations, monitoring, and all treatments will be made by the treating clinical team.

Trial Locations (1)

410000

Xiangya hospital,Central South University, Changsha

All Listed Sponsors
lead

Xiangya Hospital of Central South University

OTHER

NCT06992843 - Neuroprotection Bundles Comatose Survivors for in Cardiac Arrest Trial | Biotech Hunter | Biotech Hunter